CHNC China Infrastructure Construct

China Infrastructure Construction Corp. (OTCPK: CHNC) Announces That It Has Qualified to OTC PINK Classification

China Infrastructure Construction Corp. (OTCPK: CHNC) Announces That It Has Qualified to OTC PINK Classification

Houston, TX, July 26, 2018 (GLOBE NEWSWIRE) -- China Infrastructure Construction Corp. now (OTCPK: CHNC) announces that it has qualified as Current Information by making disclosures available directly to investors on OTC Markets Group .

OTC Markets Group (previously known as "Pink Sheets") is an American financial market providing price and liquidity information for almost 10,000 over-the-counter (OTC) securities. OTC Pink provides for transparent trading and best execution. OTC-traded securities are organized to inform investors of opportunities and risks.

Elizabeth Hernández, President & CEO, stated: “We have published the disclosures, financial reports, and an OTC attorney letter fulfilling OTC Markets standards.  The full disclosures are shown on OTC Markets-CHNC and were reviewed and approved by OTC Markets Group Issuer Compliance. We are extremely excited to be OTC PINK Current now as this demonstrates our efforts to provide investor transparency and increase shareholder value. We would like to thank our shareholders for their patience in supporting our vision."

About Hippocrates Direct Healthcare™

Hippocrates Direct Healthcare, Inc. is innovating healthcare by redefining the doctor-patient relationship. Direct access to physicians, by its clients, is the cornerstone of Hippocrates. It is understandable why patients and providers are both dissatisfied with the way medical care is delivered. From a patient’s perspective, medical care is a vast web of bureaucracy that is expensive, time consuming, and lacking in considerations for patient care and comfort. The care provided is minimal, five to ten minutes per visit at best, and one to two problems per visit as well. As a result, quality of care and results are sorely lacking—this is the TRUE cause of the crisis we face in medical care today. Hippocrates Direct will correct this problem. Hippocrates Direct offers concierge medicine through its membership-based model. The company will own and staff individual clinical facilities initially in the Houston Metro area and will expand nationwide. More information can be found online at

Hippocrates Direct Healthcare, Inc. is a wholly-owned subsidiary of China Infrastructure (OTCPK: CHNC). China Infrastructure's common stock trades on the OTC Markets under the ticker symbol "CHNC."

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

Hippocrates Direct Healthcare™ and the Hippocrates Direct Healthcare™ logo are all trademarks or registered trademarks of Hippocrates Direct Healthcare™, Inc.

CONTACTS:

Investors:

Hippocrates Direct Healthcare™, Inc.

(346) 256-4695

Media:

EN
26/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 ...

Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today that it is in the evaluation stage of a potential financing transaction under Regulation A (Reg A), in an estimated amount in the order of $1,000,000, subject to change, internal review, and applicable market and compliance conditions.CBIH clarifies that this communication reflects a serious corporate and executive planning approach intended to protect business value and accelerate operati...

 PRESS RELEASE

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr....

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding.CBIH confirms receipt of a communication from the Centers for Medicare & Medicaid Services (CMS) acknowledging Company's meeting request with CMS Administrator Dr. Mehmet Oz a...

 PRESS RELEASE

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accele...

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the launch of a national outreach and partnership initiative designed to capitalize on the accelerating federal momentum toward moving cannabis from Schedule I to Schedule III through the ongoing rescheduling rulemaking process. On December 18, 2025, a Presidential Executive Order directed the U.S. Attorney General to take necessary steps to complete the rulemaking process related to resche...

 PRESS RELEASE

CBIH Announces New Patent Initiative Targeting Opioid Addiction Throug...

Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that it is pursuing a new patent for an investigational therapy designed to address opioid addiction, a condition that continues to claim tens of thousands of lives each year in the United States.According to U.S. public health data, more than 700,000 people have died from opioid-involved overdoses since the early 2000s. Despite recent progress, the crisis remains severe: in 2024 alone, a...

 PRESS RELEASE

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Op...

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications that President Donald Trump will support federal actions that advance the rescheduling of marijuana from Schedule I to Schedule III. The development is widely regarded as one of the most consequential policy shifts in nearly two decades of national debate.After eighteen years of navigating scientific challenges, market volatility, stigma, and regulatory uncertainty, CBIH stated that this turn...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch